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EFFICACY OF INTRANASAL DESMOPRESSIN IN THE TREATMENT 
OF NOCTURIA DUE TO NOCTURNAL POL YURIA 
Naoki TERADA， Ryuichiro ARAKAKI， Yoshiyuki OKADA， Mitsuteru KITAHARA， 
Yoshiyuki KANEKO， Kohei OMORI and Kazuo NISHIMURA 
The Department 01 Urology， Osaka Red Cross Hospital 
Older adults often cite nocturia as one of the most bothersome lower urinarγtract symptoms 
(LUTS). We investigated the efficacy and safety of intranasal desmopressin in the treatment of 
nocturia due to nocturnal polyuria on 12 patients (ten men， two women) ranging in age from 53 to 77 
years (mean 67 years). All patients experienced more than two episodes ofnocturia per night， and had 
a nocturnal urine volume greater than 35% ofthe daily voided volume， measured using a 3-day voiding 
diary with a frequency-volume chart. They began taking intranasal desmopressin (10μg) at bedtime. 
When compared with the baseline data， the nocturnal urine volume， (928士307versus 469士251ml， p 
=0.0007) and nocturnal frequency (4.8:!:2.0 versus 2.8士1.8，p=0.0009) were significantly decreased. 
The daytime urine volume (1，008土458versus 930士419ml， p=0.49) did not cha時 esignificantly. 
The uni町 osmolarity(420土143versus 598土158mOsm/kg， p=0.0065)， and urine sodium levels (100 
土32versus 140土60mEq/l， p=0.007) increased significantly， whereas the serum sodium levels (141士
3 versus 135土7mEq/l， p=0.048) decreased significantly. Among the 12 patients， 5 (41.6%) patients 
reported side effects， including headache in 1， edema in 1 and hyponatremia in 3. The patient with 
edema discontinued medication， but the other 4 patients continued their medication and the side effects 
subsided. In conclusion， desmopressin is an effective treatment for adult patients complaining of 
nocturia due to nocturnal polyuria. One should be aware of the potential side effects including 
hyponatremia. 
(Hinyokika Kiyo 51: 151-154， 2005) 
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Fig. 1. Changes in the nocturnal frequency (A)， nocturnal urine volume(B)， and urine osmo-











(3-8)，平均 l日尿量 1，936:1:765 ml (1，078-
3，240 ml)，平均夜間尿量 928:1307 ml (453 -1 ，560 




Table 1. Comparison of the therapeutic effects 

















4.8土2.0 2.8土1.8* 0.0009 
225土108 193土 90 0.2004 
928士307 469土251* 0.0007 
1，008土458 930士419 0.49 
1，936土765 1，399土670* 0.01 
420土143 598土158* 0.0065 
100士 32 140土 60* 0.007 
141土 3 135土 7* 0.048 
した (p=0.0007).平均早朝尿浸透圧は 420mOsm/
kgから 598mOsm/kgに上昇 (p=0.0065)，平均尿
中 Na濃度は 100mEq/!から 140mEq/!に上昇した
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小原ら 10) 8 ( 7/1) 69 4.6 
Chancellor， eta1.14) 12 (12/0) 67 3.6 
Kuo， etal.ll) 30 (25/5) 75.4 5.6 
Mattiasson， eta1.13) 83 (83/0) 64.5 3.0 












































2.5 919 414 点、鼻 (5or10μg/day) 
1.8 971 321 スプレー (10μg/day) 
2.9 949 553 内服 (0.1mg/day) 
1.7 750 450 内服 (0.1-0.4 mg/day) 
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